The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia

Saved in:

Bibliographic Details
Published in:	Leukemia & lymphoma Vol. 55; no. 12; pp. 2935 - 2937
Main Authors:	Eskazan, Ahmet Emre, Elverdi, Tugrul, Yalniz, Fevzi Firat, Salihoglu, Ayse, Ar, Muhlis Cem, Ongoren Aydin, Seniz, Baslar, Zafer, Aydin, Yildiz, Tuzuner, Nukhet, Ozbek, Ugur, Soysal, Teoman
Format:	Journal Article
Language:	English
Published:	United States Informa Healthcare 01-12-2014 Taylor & Francis
Subjects:	Antineoplastic Agents - administration & dosage Antineoplastic Agents - economics Antineoplastic Agents - therapeutic use Benzamides - administration & dosage Benzamides - economics Benzamides - therapeutic use Chemistry, Pharmaceutical Cost-Benefit Analysis Drug Substitution Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Piperazines - administration & dosage Piperazines - economics Piperazines - therapeutic use Protein Kinase Inhibitors - administration & dosage Protein Kinase Inhibitors - economics Protein Kinase Inhibitors - therapeutic use Pyrimidines - administration & dosage Pyrimidines - economics Pyrimidines - therapeutic use
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1
ISSN:	1042-8194 1029-2403
DOI:	10.3109/10428194.2014.905774